APA (7th ed.) Citation

M, R., L, F., F, L. P., MD, R., A, S., L, A., . . . A, C. (2025). The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: A large, real-life, worldwide population. Journal of the National Cancer Institute, 117(10), 2029. https://doi.org/10.1093/jnci/djaf155

Chicago Style (17th ed.) Citation

M, Rimini, et al. "The Impact of Molecular Alterations in Patients with Advanced Biliary Tract Cancer Receiving Cisplatin, Gemcitabine, and Durvalumab: A Large, Real-life, Worldwide Population." Journal of the National Cancer Institute 117, no. 10 (2025): 2029. https://doi.org/10.1093/jnci/djaf155.

MLA (9th ed.) Citation

M, Rimini, et al. "The Impact of Molecular Alterations in Patients with Advanced Biliary Tract Cancer Receiving Cisplatin, Gemcitabine, and Durvalumab: A Large, Real-life, Worldwide Population." Journal of the National Cancer Institute, vol. 117, no. 10, 2025, p. 2029, https://doi.org/10.1093/jnci/djaf155.